Trevi Therapeutics, Inc. (TRVI)

NASDAQ: TRVI · Real-Time Price · USD

18.15

+0.15 (0.83%)

At close: Jun 26, 2026, 4:00 PM EDT

18.14

-0.01 (-0.06%)

Pre-market: Jun 29, 2026, 7:32 AM EDT

Trevi Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Selling, General & Admin	17.16	15.85	12.15	10.24	10.07	9.49
Research & Development	35.61	33.48	39.38	23.68	19.83	22.98
Total Operating Expenses	52.77	49.33	51.52	33.92	29.91	32.48
Operating Income	-52.77	-49.33	-51.52	-33.92	-29.91	-32.48
Interest Income	7.11	6.54	3.6	4.75	1.74	0.01
Interest Expense	-	-	-0	-0.39	-1.16	-1.2
Other Non-Operating Income (Expense)	-0.01	-0.03	-0.02	0.47	0.14	-0.29
Total Non-Operating Income (Expense)	7.1	6.51	3.58	4.83	0.72	-1.49
Pretax Income	-45.68	-42.82	-47.94	-29.1	-29.19	-33.96
Provision for Income Taxes	-0.1	-0.06	-0.03	0.03	0.04	0.02
Net Income	-45.61	-42.76	-47.91	-29.07	-29.15	-33.94
Net Income to Common	-45.61	-42.76	-47.91	-29.07	-29.15	-33.94
Shares Outstanding (Basic)	142	135	102	99	65	23
Shares Outstanding (Diluted)	142	135	102	99	65	23
Shares Change (YoY)	33.01%	32.14%	2.97%	53.44%	182.56%	26.48%
EPS (Basic)	-0.32	-0.32	-0.47	-0.29	-0.45	-1.49
EPS (Diluted)	-0.32	-0.32	-0.47	-0.29	-0.45	-1.49
Free Cash Flow	-45.3	-42.1	-38.29	-31.85	-28.33	-28.95
Free Cash Flow Per Share	-0.32	-0.31	-0.38	-0.32	-0.44	-1.27
EBITDA	-52.63	-49.18	-51.38	-33.8	-29.86	-32.43
EBIT	-52.77	-49.33	-51.52	-33.92	-29.91	-32.48
Effective Tax Rate	0.21%	0.15%	0.06%	-0.11%	-0.12%	-0.06%

SEC Filings: 10-K · 10-Q